Experience Litigating Paxil Injuries and Wrongful Death Cases
For more than 30 years, Baum, Hedlund, Aristei & Goldman has represented thousands of victims harmed by drug-induced injuries and wrongful death. Our firm has handled personal injury, wrongful death and consumer class action cases against some of the world’s largest drug companies, including GlaxoSmithKline (GSK), the manufacturer of Paxil.
Our attorneys have litigated various types of cases against GSK. Baum Hedlund filed its first Paxil injury lawsuit against GSK in 2001. In that litigation, our firm was appointed lead counsel in charge of the Plaintiffs’ Steering Committee for the Paxil Products Liability Litigation (Multidistrict Litigation MDL-1574) in which we represented thousands of people from across the United States dealing with Paxil injuries.
Stewart Dolin Paxil Suicide Case
Baum Hedlund currently represents the widow of Stewart Dolin, a prominent Chicago attorney who committed suicide after being on paroxetine (generic Paxil) for six days. Mr. Dolin was 57 at the time of his death.
On July 10, 2010, 57-year-old Stewart Dolin began taking the prescription antidepressant medication paroxetine. The brand name version of this medication, called Paxil, was researched, developed, manufactured and marketed by GlaxoSmithKline (“GSK”). People use the term Paxil to refer to brand name Paxil and, sometimes, to generic paroxetine. Generic and name brand Paxil are the same chemical compound and both use the same product information labeling. GSK created and was responsible for maintaining the accuracy of the Paxil label, according to the lawsuit.
The lawsuit alleges GSK failed to adequately warn Mr. Dolin’s doctor about Paxil/paroxetine’s association with an increased risk of suicidal behavior in adults of all ages. The Court previously ruled that, although GSK did not manufacture the pills Mr. Dolin ingested, the company was responsible for the label and knew or should have known any failure to warn would result in harm to those taking generic versions of the drug.
In the early afternoon on July 15, 2010, Stewart Dolin died when he was struck by a CTA Blue-Line train in the subway station near Washington Street in Chicago. Just before this, a nurse at the subway station, who did not know Mr. Dolin, noticed he was pacing back and forth while looking in the direction of an approaching train that was not yet in sight. When the moving train appeared, the nurse observed Mr. Dolin leap in front of the train, where he was struck. Ultimately, Mr. Dolin was pronounced dead from the injuries he suffered due to the collision and his contact with the electrified track after the collision.
According to the lawsuit, Stewart Dolin exhibited classic symptoms of akathisia—a drug-induced phenomenon that causes extreme restlessness, agitation and mental distress—before he took his own life. Akathisia has been linked to suicidal and homicidal behavior.
The only other Paxil suicide case (which involved a triple homicide) to go to trial was in 2001 in Cheyenne, Wyoming and resulted in a multi-million-dollar verdict in favor of the Plaintiff. This murder-suicide case, known as Tobin v. SmithKline Beecham Pharmaceuticals, involved Donald Schell, who shot and killed his wife, his daughter, his granddaughter and then himself while under the influence of Paxil.